Beyond the science, Greg reflects on the clinical potential of phage therapy and the challenges of bringing it closer to medical practice. He also shares valuable career insights and advice for early-stage researchers navigating the field. Enjoy! 🎧.

Also about phage resistance, the different responses of MSSA and MRSA strains, the role of glycosylation, and the regulatory landscape for phage therapy in Switzerland.

New episode out! .We had the pleasure of talking with Grégory Resch (@CHUVLausanne ) about phage - antibiotic combination against endocarditis. Our conversation ranges from detecting single phage lysis with microfluidics, to combining phages with antibiotics to tackle S. aureus.

In our most recent episode with Tristan Ferry, we learned about the importance of compassionate use cases, to learn more about treatments, leading to reliable data to precede clinical trials. Get all details here:.

On the personal side we could hear a more personal view of his work, how it is to manage such responsibilities, financial pressures of the scientific system and one of the best pieces of advice for PhD students. Enjoy!🎧.

🎙️We are happy to share our most recent episode with @FerryLyon . We talk about how phage therapy is managed in France and focus on how phages are used against implant-associated infections, what are the pathogens involved and what is the best phage administration route.

Couldn’t attend the First International Symposium on Advances in Phage Therapeutics? We've got you covered!. Listen to this new episode featuring a full roundtable discussion, where experts explored the future of phage therapy. 🔗

Moderated by @MartinLoessner from ETH Zürich , with a discussion featuring @RobLavigne1 from KU Leuven, @PaulPirnay and Sara Djebara from the Queen Astrid Military Hospital, and Mzia Kutateladze from the Eliava Phage Therapy Center.

🎙️ New episode out!.This time it´s not us speaking, you will hear experts opinion on phage therapy, a round table from the First International Symposium on Advances in Phage Therapeutics @AzeredoLab .All the open questions about phage therapy discussed in one place! Enjoy!

We will be attending the 1st symposium in Advances in Phage Therapeutics, in Braga, Portugal! . Looking forward to taking part and to see you all there next week!.

RT @phagedirectory: .@AHarms485 was interviewed on the @PhageCast podcast about the Basel Phage Collection, basic science insights from E.….

Did you know some phages have covalent genome modifications to avoid Restriction-Methylation systems? . Wanna know a famous phage that does this? . Listen to the episode here:.

This episode was sponsored by PrecisionPhage:. ⁠ Try Phagenomics for free at ⁠ and sign up for a pro subscription trial.

In the end of the conversation, Alexander shares his path into phage research, the role of failure in science, and his advice to young researchers. Enjoy 🎧.

Why K12 was chosen as the host, what shapes host range in E. coli phages, insights into anti-phage defense systems, how AI could support phage prediction and design, and the key assays used to characterize phages, it was some of the questions answered during the conversation.

We explored what makes E. coli phages particularly interesting — and how insights from the Basel Phage Collection could shape therapeutic development and rational phage engineering.

🎙 New Episode Out!.In this episode, we had the pleasure of talking with @AHarms485 researcher and professor at ETH Zürich, about a well-known resource in phage biology: the Basel Phage Collection. Listen here:.

We asked leading scientists in the phage world to share their favorite failures. The ones that taught them the most!.Their stories are insightful, surprising, and inspiring. If you have not listened yet tune in now at Which failure resonates most with you?.

Did you know that bacterial L-forms are a way of resistance to endolysins?. Revisit our conversation with @MartinLoessner to hear all details about it:.